
What CapyBio Can Tell You That Standard scRNA-seq Clustering Misses
Clusters are maps, not biology. Cells that share a UMAP island can still differ in maturity, activation state, and how closely they match the human cell type a study actually needs.
Short takes from the CapyBio team on cell identity, engineering, and the science shaping better cells.

Roughly nine in ten drug candidates fail in the clinic, and species differences are part of the reason why. Human stem cell models offer a way to close that gap, but only if the cells are what they claim to be.

The next phase of stem cell biology will depend on fit-for-purpose evidence: not simply whether a human cell model can be built, but whether it is the right model for the decision it is meant to support.

Standard QC can confirm what cells look like, but not what they are doing. That gap gets expensive downstream.